Conrad En Zuo Chan

机构：Agency for Science, Technology and Research, National Environment Agency, National Centre for Infectious Diseases · ORCID：0000-0001-5730-7095

发表论文 33 篇 · 总被引 701 次 · h-index 15

代表论文

• The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibody (2021 · PLoS ONE · 被引 106)
• Structural insight into SARS-CoV-2 neutralizing antibodies and modulation of syncytia (2021 · Cell · 被引 83)
• Enhancing vaccine antibody responses by targeting Clec9A on dendritic cells (2017 · npj Vaccines · 被引 50)
• IDentif . AI : Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐Cov‐2) with digital drug development (2020 · Bioengineering & Translational Medicine · 被引 45)
• Defining the structural basis for human alloantibody binding to human leukocyte antigen allele HLA-A*11:01 (2019 · Nature Communications · 被引 36)
• The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibody (2020 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 32)